Positive One-Year Outcomes for BioVentrix Revivent TC™
The BioVentrix Revivent TC™, the first "less invasive" system for left ventricular remodeling, has yielded positive one-year results in an online publication of the European Journal of Heart Failure. Based on a CE Mark study, the paper will be published in print in the January issue of the...
Latest News
Cardiology
Approvals / Clearance
XACT Robotic System Cleared by FDA for Percutaneous Interventional Procedures
read the full article >CE Mark for Boston Scientific's VERCISE™ Neural Navigator 3 Programming Software
Boston Scientific Corporation has announced the CE Mark approval of its Vercise™ Neural...
read the full article >
Clinical Studies / Trials
Abbott Launches World's First Pivotal Trial to Test Leaky Tricuspid Heart Valve Repair System
Abbott has announced the launch of the TRILUMINATE Pivotal trial to evaluate the safety and...
read the full article >CE Mark for Orchestra BioMed BackBeat Cardiac Neuromodulation Therapy™ for Hypertension
Orchestra BioMed™, Inc., tells us it has received CE Mark approval for its...
read the full article >